Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:

Shopify (SHOP) : "This has been a hot stock but it's up too much, too fast. You need to wait for 10 points down."

Kinder Morgan (KMI) : "That's one of the worst stocks to own in this environment."

Thermo Fisher Scientific (TMO) : "I think this one is ideal. The quarter was monster. Don't buy it all at once though."

Radius Health (RDUS) : "That's the exact wrong stock to own in this environment. We have Eli Lilly (LLY) , Merck (MRK) and Pfizer (PFE) , let's stick with those. "

Halozyme Therapeutics (HALO) : "I want to sell this one and go with General Dynamics (GD) ."

Cramer and the AAP team say this is exactly the kind of volatility they added a blanket of protection for when they raised cash on Tuesday. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

Over on Real Money, Cramer says isn't the end of the world. But it is time for investors to recognize peril, not just profits. Get more of his insights with a free trial subscription to Real Money.

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

To read a full recap of this episode of "Mad Money," click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had a position in LLY.

More from Jim Cramer

Carnival, Advanced Micro Devices, Iridium: 'Mad Money' Lightning Round

Carnival, Advanced Micro Devices, Iridium: 'Mad Money' Lightning Round

Our Economy's Strong: Cramer's 'Mad Money' Recap (Wed. 7/18/18)

Our Economy's Strong: Cramer's 'Mad Money' Recap (Wed. 7/18/18)

Rewind: Why Jim Cramer Is Bullish on Johnson & Johnson Shares

Rewind: Why Jim Cramer Is Bullish on Johnson & Johnson Shares

Biotech's Coming Back to Life: Cramer's 'Off the Charts'

Biotech's Coming Back to Life: Cramer's 'Off the Charts'

Jim Cramer: Bank of America Expects 4% Economic Growth in Q2

Jim Cramer: Bank of America Expects 4% Economic Growth in Q2